The effect of intermedin on angiotensin ii and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat

Clinical Laboratory

Volumn 59, Issue 5-6, 2013, Pages 589-596

  Liu, Kai ^a   Deng, Xiaoming ^a   Gong, Ling ^a   Chen, Xiaoping ^a   Wang, S I ^a   Chen, Hongying ^b   Chen, Xiaoni ^a   Amrit, Bogati ^a   He, Sen ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Myosin heavy chain; Alpha actin; Ang II; Cardic myocyte hypertrophy; Et 1; Gp91phox; Intermedin

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN II; ENDOTHELIN 1; INTERMEDIN; MYOSIN HEAVY CHAIN BETA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL SIZE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACTINS; ADRENOMEDULLIN; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELL SIZE; CELLS, CULTURED; DRUG INTERACTIONS; ENDOTHELIN-1; GENE EXPRESSION; HEART VENTRICLES; MEMBRANE GLYCOPROTEINS; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; NADPH OXIDASE; NEUROPEPTIDES; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION;

RATTUS;

EID: 84879331927     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120708     Document Type: Article

References (35)

1. Laskowski A, Woodman OL, Cao AH, et al. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 2006;72:112-23. (Pubitemid 44310640)
2. Olivetti G, Cigola E, Maestri R, et al. Recent advances in cardiac hypertrophy. Cardiovasc Res 2000;45: 68-75.
3. Hunt SA, Abraham WT, Chin MH, et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:1-90.
4. Authors/Task Force Members, McMurray JJ, Adamopoulos S, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847.
5. Richer C, Fornes P, Domergue V, et al. Combined Angiotensin II AT1-Receptor Blockade and Angiotensin I-Converting Enzyme Inhibition on Survival and Cardiac Remodeling in Chronic Heart Failure in Rats. Journal of Cardiac Failure 2001;7:269-76. (Pubitemid 32867968)
6. Bangalore S, Messerli FH, Kostis JB, et al. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol 2007;50:563-72. (Pubitemid 47202065)
7. Pan CS, Yang JH, Cai DY, et al. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin-2. Peptides 2005;26:1640-6.
8. Bell D, McDermott BJ. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems. Br J Pharmacol 2008;153 Suppl 1:247-62.
9. Takei Y, Inoue K, Ogoshi M, et al. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 2004;556:53-8. (Pubitemid 38058554)
10. Burak-Kandilci H, Gumusel B, Wasserman A, et al. Intermedin/ adrenomedullin dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release. Peptides 2006;27:1390-6. (Pubitemid 43766994)
11. Roh J, Chang CL, Bhalla A, et al. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 2004;279:7264-74. (Pubitemid 38248876)
12. Fujisawa Y, Nagai Y, Miyatake A, et al. Effects of adrenomedullin-2 on regional haemodynamics in conscious rats. Eur J Pharmacol 2007;558:128-32. (Pubitemid 46328879)
13. Yang JH, Jia YX, Pan CS, et al. Effects of intermedin (1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts. Biochem Biophys Res Commun 2005;327:713-9.
14. Yang JH, Qi YF, Jia YX, et al. Protective effects of intermedin/ adrenomedullin-2 on ischemia/reperfusion injury in isolated rat hearts. Peptides 2005;26:501-7.
15. 1-53 attenuating myocardial oxidative stress injury induced by ischemia/reperfusion. Peptides 2012;33:329-35.
16. Bell D, Zhao YY, Devine AB, et al. Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components. Cell Physiol Biochem 2008;21:203-14.
17. Bell D, Zhao Y, McCoy FP, et al. Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes. Cell Physiol Biochem 2008;21:409-20. (Pubitemid 351620294)
18. Tsuruda T, Kato J, Kitamura K, et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 1998;31:505-10.
19. Rosenkranz AC, Woods RL, Dusting GJ, et al. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res 2003;57:515-22. (Pubitemid 36144228)
20. Rosenkranz AC, Hood SG, Woods RL, et al. B-type-natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP. Diabetes 2003;52:2389-95. (Pubitemid 37059511)
21. Wang C, Dobrzynski E, Chao J, et al. Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 2001;280:964-71.
22. Niu P, Shindo T, Iwata H, et al. Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice. Hypertens Res 2003;26:731-6. (Pubitemid 37258661)
23. 1-53 on angiotensin II-induced hypertrophy in neonatal rat ventricular myocytes. J Cardiovasc Pharmacol 2010;56:45-52.
24. Danser AH. Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 2003;35:759-68. (Pubitemid 36379316)
25. vanKats JP, Methot D, Paradis P, Silversides DW, Reudelhuber TL. Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem 2001;276:44012-7.
26. Sun Y. Myocardial repair/remodeling following infarction: roles of local factors. Cardiovasc Res 2009;81:482-90.
27. Xu J, Carretero OA, Liao TD, et al. Local angiotensin II aggravates cardiac remodeling in hypertension. Am J Physiol Heart Circ Physiol 2010;299:1328-38.
28. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001;14:83-9.
29. Li L, Chu Y, Fink GD, et al. Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension 2003;42:997-1003. (Pubitemid 37413744)
30. Li L, Fink GD, Watts SW, et al. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 2003;107: 1053-8. (Pubitemid 36258731)
31. Dong F, Zhang X, Wold LE, et al. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 2005;145:323-33. (Pubitemid 40896077)
32. Brunt KR, Tsuji MR, Lai JH, et al. Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes. Exp Biol Med (Maywood) 2009;234:582-94.
33. Yamamoto M, Yang G, Hong C, et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 2003;112:1395-406. (Pubitemid 38057693)
34. Ushio-Fukai M, Zafari AM, Fukui T, et al. p22phox ¡s a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996;271:23317-21. (Pubitemid 26314775)
35. Kenji Dohi, Hirokazu Ohtaki, et al. Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury. J Neuroinflammation 2010;7:41. Republic of China